Evidence map›Paper›PMID 40827152›Full record

ArticleCureus2025

Recurrent Periocular Nodules: Lymphomatoid Papulosis in an Uncommon Anatomic Site.

Alexa Lum, Jessica Colon, Kristi Hawley

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexa LumDermatology, Michigan State University College of Osteopathic Medicine, East Lansing, USA.
Jessica ColonInternal Medicine, Memorial Healthcare System, Pembroke Pines, USA.
Kristi HawleyDermatology, The Derm Institute of West Michigan, Caledonia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphomatoid papulosis (LyP) is a rare cutaneous lymphoproliferative disorder involving the dysregulation of CD30-positive T-cells that accumulate in the skin. The accumulation of CD30-positive T-cells leads to the development of papulonodular lesions, which typically follow a protracted course and often resolve spontaneously in a matter of days to weeks. This case report describes a 44-year-old male patient who initially presented to the dermatology office with recurrent nodules under the right eye. He was diagnosed with periocular dermatitis initially, but when his condition failed to improve with minocycline, he was subsequently diagnosed with papulopustular rosacea and impetigo. However, despite multiple treatment trials, he still experienced recurrent flares with nodules that would arise only under the right eye and subsequent pain, swelling, and inflammation, which subsided as the lesions resolved. Histopathology of one of the lesions revealed a CD30-positive atypical lymphoid infiltrate, consistent with a diagnosis of LyP. Due to its close resemblance to other lymphoproliferative diseases, a diagnosis of LyP requires characteristic histological findings and a compatible clinical presentation, as neither alone is sufficient for diagnosis. This case report highlights the importance of integrating both clinical presentation and histopathologic findings to establish a diagnosis of LyP, especially when it arises in an uncommon anatomic site. LyP typically follows a benign course, but all patients diagnosed with LyP should have regular visits with a hematologist/oncologist to monitor for potential progression to malignant lymphoma.

Indexed as

cd30-positive lymphoproliferative disorderschronic lymphoproliferative diseasescutaneous t-cell lymphoma (ctcl)lymphomatoid papulosispapulonodular disease

Identifiers

PMID40827152
PMCPMC12358051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.